a b s t r a c t
Metabotropic glutamate receptors (mGluRs) are densely expressed in the limbic system of the mammalian brain. Increasing evidence suggests a critical role of mGluRs in the pathogenesis of various mental illnesses, including drug abuse and addiction. In this study, we investigated the effect of psychostimulant, cocaine, on protein expression of a specific mGluR subtype, mGluR8, in the rat forebrain in vivo. A rabbit antibody against the extracellular N-terminus of mGluR8 was developed to detect changes in mGluR8 proteins in immunoblot assays. With this antibody, we found that acute systemic injection of cocaine reduced mGluR8 protein levels in the striatum. The reduction of mGluR8 proteins was rapid and transient as it was induced 25 min after cocaine injection and returned to the normal level by 6 h. No significant change in mGluR8 protein levels in the prefrontal cortex and the hippocampus was observed following cocaine administration. These data demonstrate that protein expression of mGluR8 is subject to the modulation by dopamine stimulation. Acute exposure to cocaine results in a dynamic and region-specific downregulation of mGluR8 expression in the striatum.
Metabotropic glutamate receptors (mGluRs) are G protein-coupled receptors that are densely expressed in brain cells. Eight subtypes of mGluRs so far cloned from the rat brain are heterogeneous in their physiology and connections to intracellular signaling pathways. Group I mGluRs (mGluR1/5 subtypes) are positively coupled to phospholipase C␤1 (PLC␤1) through G␣q proteins. Activation of mGluR1/5 then increases phosphoinositol hydrolysis, followed by intracellular Ca 2+ release and protein kinase C activation [4] . Both group II (mGluR2/3) and group III (mGluR4/6/7/8) receptors are negatively coupled to adenylyl cyclase through Gi/o proteins. Activation of these receptors leads to inhibition of protein kinase A activity and cAMP production [4] . A large number of morphological studies have demonstrated expression of most mGluR subtypes in the striatum at variable levels [8, 23, 25] . The enriched mGluR distribution in this region indicates putative involvements of mGluRs in the regulation of striatal function.
The striatum is a key structure of the basal ganglia and a direct target of many addictive drugs, including psychostimulant cocaine.
It has been well documented that cocaine, by blocking reuptake of dopamine into nerve terminals, increases synaptic dopamine levels in the striatum, which thereby enhances the basal ganglia outflow to the cerebral cortex, leading to stimulation of motor activity [3, 9] . The enhanced dopaminergic transmission also induces changes in gene expression in postsynaptic medium spiny projection neurons in the striatum. These drug-regulated changes in gene expression are thought to be essential components of molecular adaptations to drug exposure, which constitutes a transcription-dependent mechanism underlying the long-lasting addictive properties of drugs of abuse [14, 16, 26] . mGluR8 is among the mGluR subtypes that are densely expressed in the forebrain regions, including the striatum [15] . Increasing evidence indicates that this subtype of mGluRs plays a significant role in the regulation of normal mental function and in the pathogenesis of various forms of psychiatric illnesses [17, 20] . It is possible that mGluR8 expression and function in the striatum are linked to psychostimulant action. In this study, we attempted to investigate the effect of cocaine on basal levels of mGluR8 proteins in the rat striatum. A rabbit antibody against mGluR8 was produced for this purpose. Alterations in mGluR8 protein abundance in the striatum and other forebrain regions in response to a single injection of cocaine were assayed using immunoblot with this antibody. Adult male Wistar rats weighing 200-225 g (Charles River, New York, NY) were individually housed in clear plastic cages. An at least 5-day accommodation period was allowed prior to the commencement of the experiment. Animals were maintained on a 12/12-h light-dark cycle; lights were turned on at 7:00 a.m. The housing environment was maintained at 23 • C and humidity at 50 ± 10% with food and water available ad libitum. All procedures performed were approved by the Institutional Animal Care and Use Committee and were in accordance with the NIH Guide for the Care and Use of Laboratory Animals.
Saline or cocaine hydrochloride (Sigma-Aldrich, St. Louis, MO) was injected intraperitoneally (i.p.). Doses of cocaine were calculated on salt. Rats were anesthetized with Equithesin (9 ml/kg, i.p.) and decapitated 25 min after cocaine injection or at the survival time indicated. The selection of 25 min was based on our preliminary studies in which cocaine at this time point caused a reliable change in mGluR8 protein levels in the striatum. Brains were removed, and the entire striatum, including the dorsal caudate putamen and ventral nucleus accumbens, the prefrontal cortex, and the hippocampus were separately removed into a 1.5-ml microtube containing ice-cold sample buffer (20 mM Tris-HCl, pH 7.4, 1 mM dithiothreitol, 10 mM NaF, 2 mM Na 3 VO 4 , 1 mM EDTA, 1 mM EGTA, 5 M microcystin-LR, and 0.5 mM phenylmethylsulfonyl fluoride). The sample was homogenized by sonication. The homogenate was centrifuged at 700 × g for 10 min at 4 • C. The supernatant was again centrifuged at 10,000 × g at 4 • C for 30 min to generate the crude synaptosomal pellet (P2). The P2 pellet was resuspended in ice-cold sample buffer. Protein concentrations were determined. The equal amount of protein (20 g/20 l/lane) was separated on SDS NuPAGE Novex 4-12% gels (Invitrogen, Carsbad, CA). Proteins were transferred to polyvinylidene fluoride membrane (Millipore, Bedford, MA) and blocked in blocking buffer (5% nonfat dry milk in phosphate-buffered saline and 0.1% Tween 20) for 1 h. The blots were washed and incubated in the blocking buffer containing a primary rabbit antibody against mGluR8 (see below) or actin (Santa Cruz Biotechnology, Santa Cruz, CA) usually at 1:1000 overnight at 4 • C. This was followed by 1 h incubation in a goat horseradish peroxidase-linked secondary antibody against rabbit (Jackson Immunoresearch Laboratory, West Grove, PA) at 1:5000. Immunoblots were developed with the enhanced chemiluminescence reagents (ECL; Amersham Pharmacia Biotech, Piscataway, NJ), and captured into Kodak Image Station 2000R. Kaleidoscopeprestained standards (Bio-Rad, Hercules, CA) and MagicMark XP Western protein standards (Invitrogen) were used for protein size determination. The density of immunoblots was measured using the Kodak 1D Image Analysis software [10, 13] .
A rabbit polyclonal antibody recognizing mGluR8 was generated by Quality Controlled Biochemicals (Hopkinton, MA). Rabbits were immunized with a synthetic peptide Ac-ELKKEKGIHRLEAMLYAIC corresponding to N-terminal extracellular amino acids 66-84 of rat mGluR8 [21] . Sera were collected and affinity-purified using the antigen peptide.
The results are presented as mean ± S.E.M., and were evaluated using a one-or two-way analysis of variance, as appropriate, followed by a Bonferroni (Dunn) comparison of groups using least squares-adjusted means. Probability levels of <0.05 were considered statistically significant.
A rabbit antibody against mGluR8 was produced to assay changes in mGluR8 protein abundance in brain cells in response to cocaine stimulation. The selectivity of this antibody was first verified in a series of control experiments. Omission of the antimGluR8 antibody in Western blot analysis produced no visible immunoreactive bands. Addition of the antibody produced a single strong immunoreactive band at a molecular weight predicted for mGluR8 (∼102 kDa) in striatal protein extracts (Fig. 1) . Pre-absorption of the antibody with the immunogen peptide (Ac-ELKKEKGIHRLEAMLYAIC) prevented the mGluR8 band (Fig. 1) . These results collectively validate the selectivity of this mGluR8 antibody.
We then used the antibody to probe changes in mGluR8 protein levels following cocaine administration in vivo. A Single injection of cocaine (5 mg/kg, i.p., 25 min prior to protein collection) caused a marked decrease in mGluR8 proteins in the rat striatum (Fig. 2) . The mGluR8 protein level in cocaine-treated rats was reduced to 62.1 ± 3.7% (p < 0.05) of that in saline-treated rats (Fig. 2) . Similar to 5 mg/kg of cocaine, cocaine at 20 mg/kg caused a comparable decrease (52.0 ± 13.2% of control, p < 0.05) in mGluR8 proteins in the striatum (Fig. 2) . There was no statistically significant difference in extent of the reduction of mGluR8 proteins between 5 and 20 mg/kg of cocaine, regardless that cocaine at the two doses caused a dose-dependent increase in motor activity. While cocaine at 5 mg/kg induced no or little increase in behavioral activity, the drug at 20 mg/kg induced robust and typical behavioral responses to cocaine (increased levels of locomotion or stereotypical behaviors characterized by repetitive sniffing and exploration). These results demonstrate a supersensitive nature of mGluR8 expression to cocaine exposure. Even at a behaviorally inactive dose (5 mg/kg), cocaine was able to induce a considerable decrease in mGluR8 proteins in the striatum.
A time-course study was carried out to characterize the temporal property of the reduction of mGluR8 in rats treated with acute injection of saline or cocaine at either 5 or 20 mg/kg. At 20 mg/kg, as shown in Fig. 3 , cocaine reduced basal levels of mGluR8 proteins in the striatum at an early time point (25 min after injection). This reduction remained at 60 min. A reversible nature of the reduction was demonstrated. At 6 h, the cocaine-induced decrease in mGluR8 expression gradually returned to a level close to the normal value (Fig. 3) . Throughout the time course surveyed, actin proteins did not exhibit any significant change in the striatum (Fig. 3) . Similar results were observed when cocaine was administered at 5 mg/kg (data not shown). The data here display a relatively rapid and transient change in striatal mGluR8 protein expression in response to acute cocaine administration.
Other forebrain structures, including the prefrontal cortex and the hippocampus, express mGluR8, and are implicated in processing drug effects [1, 27] . We then investigated whether mGluR8 expression in these regions is subject to the modulation by cocaine. The mGluR8 protein level in the prefrontal cortex showed no change in rats treated with cocaine (20 mg/kg, 25 min) as compared to that in rats treated with saline (Fig. 4A) . Similarly, mGluR8 levels in the hippocampus were not different between cocaine-and saline-treated rats (Fig. 4B ). These data demonstrate that mGluR8 in these two structures is insensitive to cocaine, and cocaine appears to induce a region-specific downregulation of mGluR8 in the striatum.
This study investigated the effect of acute cocaine administration on mGluR8 expression in the rat forebrain in vivo using a newly developed antibody. The results indicate that mGluR8 is a sensitive target of cocaine as its protein expression can be readily regulated by the drug. A single dose of cocaine induced a profound decrease in mGluR8 protein abundance in the striatum. The decrease in mGluR8 proteins was seen as early as 25 min after drug injection, and returned to the normal level by 6 h. Of note, mGluR8 protein levels in the other forebrain regions (the prefrontal cortex and the hippocampus) remained stable after acute cocaine injection. These data reveal mGluR8 as a subtype of mGluRs, protein expression of which is under control of dopamine inputs.
Cocaine induced a dose-dependent increase in behavioral activity. In contrast, cocaine seemed to reduce mGluR8 expression in a dose-independent manner. That is, cocaine at the low (5 mg/kg) and moderate (20 mg/kg) doses reduced mGluR8 expression to a similar extent. The mechanism underlying the different behavioral and neurochemical responses to a low dose of cocaine is unclear. Perhaps, in addition to the reduction of mGluR8 expression, other receptors or neurochemical systems are needed to be altered in order to constitute an acute behavioral response to cocaine. These receptors and neurochemical systems are preferentially and adequately activated by a higher dose of cocaine (20 mg/kg).
Like other group III mGluR subtypes, mGluR8 is predominantly presynaptic in the striatum [22, 24] . Specifically, mGluR8 is believed to reside upon the corticostriatal terminals within the striatum. Thus, the downregulation of mGluR8 proteins in the striatum observed in this study primarily reflects a loss of mGluR8 in these corticostriatal terminals following dopamine stimulation. The cerebral cortex is known to project massively and topographically upon the striatum [2, 6] . Given the fact that mGluR8 is negatively coupled to the adenylyl cyclase-cAMP pathway, presynaptic mGluR8 likely exerts an inhibitory effect on glutamate release from corticostriatal terminals (see below). The loss of presynaptic mGluR8 can therefore result in disinhibition of glutamatergic transmission at corticostriatal synapses, which, in concert with other mechanisms, mediates behavioral responses to acute cocaine stimulation. Of note, in response to chronic amphetamine treatments (twice daily for 12 days, 5 mg/kg per injection), mGluR8 mRNA levels were elevated in the striatum and cerebral cortex [18] . Thus, it is possible that mGluR8 protein expression in the striatum may be upregulated by chronic cocaine or amphetamine administration as opposed to the downregulation of mGluR8 proteins in response to acute drug administration. This upregulation may reflect a compensatory response and serve to suppress the behavioral response and plasticity to chronic drug exposure. While functional roles played by mGluR8 are far from clear, available data from pharmacological studies indicate that group III mGluRs are involved in the regulation of transmitter release and behavioral plasticity in the limbic system. Activation of Gi/ocoupled group III mGluRs with the group III-selective agonist l-2-amino-4-phosphonobutyrate (l-AP4) reduced extracellular levels of dopamine in the striatum [7, 11] , indicating a tonic inhibitory tone of group III mGluRs on basal dopamine release. l-AP4 also depressed (1) the 4-aminopyridine-evoked glutamate release in striatal synaptosomal preparations [5] , and (2) the excitatory postsynaptic potentials at rat corticostriatal synapses evoked by cortical stimulation [1, 19] . Since l-AP4 did not alter the postsynaptic response to focal application of glutamate, the l-AP4 effect was believed to be mediated via a presynaptic mechanism, i.e., an existence of the group III autoreceptor-mediated presynaptic inhibition of excitatory transmission at corticostriatal synapses. The data from behavioral studies also show an inhibitory role of mGluR8 in regulating motor responses to stimulants. Microinjections of l-AP4 into the dorsal striatum blocked hyperlocomotion induced by acute injection of cocaine or amphetamine [12] . The blocking effect of l-AP4 was reversed by a group III antagonist ␣-methyl-4-phosphonophenylglycine (MPPG) [12] . Together, the accumulative data suggest an active role of group III mGluRs in regulating stimulant action usually in an inhibitory fashion. However, the specific contribution of mGluR8 to a given group III-mediated function in modifying transmitter release and motor activity remains elusive. At present, we can only assume that the downregulation of mGluR8 protein expression in the striatum may reflect a partial loss of mGluR8 autoreceptors on corticostriatal terminals, which may further translate to a reduction of the inhibitory tone of mGluR8 over glutamatergic transmission. This transient removal of the mGluR8-mediated inhibitory tone may be necessary for stimulants to enhance local glutamate release and stimulate motor activity. Further studies are important to elucidate the precise role of mGluR8 in regulating acute neuronal and behavioral responses to stimulants.
